alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › lipid-lowering

lipid-lowering

5 studies tagged lipid-lowering, dated 2003-02-01 to 2020-01-01. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. Lipid lowering and Alzheimer disease risk: A mendelian randomization study 2020-01-01
  2. Gemfibrozil, a Lipid-Lowering Drug, Lowers Amyloid Plaque Pathology and Enhances Memory in a Mouse Model of Alzheimer's Disease via Peroxisome Proliferator-Activated Receptor α 2019-05-18
  3. Gugulipid, an extract of Commiphora whighitii with lipid-lowering properties, has protective effects against streptozotocin-induced memory deficits in mice 2007-04-03

Studies

5 studies carry this tag.

Date range

2003 to 2020

Top journals

  • Annals of neurology 1
  • Journal of Alzheimer's disease reports 1
  • Journal of neurology, neurosurgery, and psychiatry 1
  • Pharmacology, biochemistry, and behavior 1
  • The American journal of cardiology 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Lipid lowering and Alzheimer disease risk: A mendelian randomization study

    ✓ Peer-reviewed alzhub usefulness score 78 out of 100. Annals of neurology 2020-01-01 Drug development

    We did not identify genetic support for the repurposing of statins, ezetimibe, or mipomersen for AD prevention.

  2. Gemfibrozil, a Lipid-Lowering Drug, Lowers Amyloid Plaque Pathology and Enhances Memory in a Mouse Model of Alzheimer's Disease via Peroxisome Proliferator-Activated Receptor α

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. Journal of Alzheimer's disease reports 2019-05-18 Treatments

    Deposition of extracellular senile plaques containing amyloid-β is one of the major neuropathological characteristics of Alzheimer's disease (AD).

  3. Gugulipid, an extract of Commiphora whighitii with lipid-lowering properties, has protective effects against streptozotocin-induced memory deficits in mice

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Pharmacology, biochemistry, and behavior 2007-04-03 Drug development

    Intracerebral (ic) injections of STZ (0.5 mg/kg) on 1st and 3rd day caused significant deficit in memory in passive avoidance and Morris water maze test after the 14th day of first dose.

  4. Lipid lowering agents are associated with a slower cognitive decline in Alzheimer's disease

    ✓ Peer-reviewed alzhub usefulness score 47 out of 100. Journal of neurology, neurosurgery, and psychiatry 2005-12-01 Drug development

    LLAs may slow cognitive decline in Alzheimer's disease and have a neuroprotective effect.

  5. Prevention of stroke and dementia with statins: Effects beyond lipid lowering

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. The American journal of cardiology 2003-02-01 Drug development

    Stroke is a major cause of mortality and morbidity.

All topic tags with their study counts